This week's roundup of Houston innovators includes Craig Ceccanti of T-Minus Solutions, Katie Eick of Rockin' Pets, Rollin' Vets, and Blair Garrou of Mercury. Photos courtesy

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from venture capital to software — recently making headlines in Houston innovation.


Craig Ceccanti, founder and CEO of T-Minus Solutions

Words of wisdom from a founder who's done this all before. And then again. And again. Photo courtesy of T-Minus Solutions

After starting a company or two — or three — Craig Ceccanti has some observations on his own entrepreneurial journey. He also has some hard lessons learned, and he shared four of them in a guest column for InnovationMap.

"I’m not immune to making mistakes," he writes. "As a serial entrepreneur and having started, led, and mentored various successful companies, I have made some mistakes and have been lucky enough to learn from them."Read more.

Katie Eick, founder and CEO of Rockin' Pets, Rollin' Vets

Katie Eick, founder and CEO of Rockin' Pets Rollin' Vets joins the Houston Innovators Podcast to discuss her company's growth. Photo courtesy of Rollin' Vets

For years, Dr. Katie Eick wanted to provide mobile veterinary care for her patients, but the technology wasn't where it needed to be. She took a gamble and bought her first truck in 2016 as ridesharing and mobile ordering took off. A new business of convenience was booming, before blasting off again amid the pandemic.

Now, the founder and CEO of Rockin' Pets, Rollin' Vets says she's got the equipment, the market demand, and a $5 million round of investment to expand her business model.

The other challenge Eick says she faced early on was a misconception that mobile vet care was limited to vaccinations.

"We provide the highest level of veterinary care — right in your driveway," Eick says on this week's episode of the Houston Innovators Podcast, explaining how each of her trucks — she now has five — have the capability to provide all sorts of treatment. Read more.

Blair Garrou, founder and managing partner of Mercury

Blair Garrou will be recognized as the 2022 Trailblazer Award recipient at the Houston Innovation Awards Gala on November 9. Photo courtesy

The name Blair Garrou is quite familiar to most within Houston's startup and innovation ecosystem. As co-founder of Mercury, which launched in 2005, he's seen the city's tech world expand tenfold.

"Although we are in the midst of a recession, Houston continues to grow in three key industrial sectors of innovation – EnergyTech/ClimateTech, HealthTech, and SpaceTech. Our city has the opportunity to be a national leader in each of these sectors, and drive tremendous job growth in the future," he tells InnovationMap.

Garrou was nominated and selected by a group of judges to be the 2022 Trailblazer Award recipient, and will be honored at the Houston Innovation Awards Gala on November 9. Read more.

Katie Eick, founder and CEO of Rockin' Pets Rollin' Vets joins the Houston Innovators Podcast to discuss her company's growth. Photo courtesy of Rollin' Vets

Houston innovator grows mobile vet clinic amid growing industry challenges

HOUSTON INNOVATORS PODCAST EPISODE 156

For years, Dr. Katie Eick wanted to provide mobile veterinary care for her patients, but the technology wasn't where it needed to be. She took a gamble and bought her first truck in 2016 as ridesharing and mobile ordering took off. A new business of convenience was booming, before blasting off again amid the pandemic.

Now, the founder and CEO of Rockin' Pets, Rollin' Vets says she's got the equipment, the market demand, and a $5 million round of investment to expand her business model.

The other challenge Eick says she faced early on was a misconception that mobile vet care was limited to vaccinations.

"We provide the highest level of veterinary care — right in your driveway," Eick says on this week's episode of the Houston Innovators Podcast, explaining how each of her trucks — she now has five — have the capability to provide all sorts of treatment.

"We have a surgery suite, we have high-speed dental equipment — just like your dentist has. We have X-ray machines and ultrasound machines on almost all of our trucks," she explains. "We carry a full pharmacy on every truck."

It took a while to get to where she is today, which is caring for clients across Houston, with a recent expansion into The Woodlands and a soft launch in Austin. She plans to expand in Central Texas, including San Antonio, before tackling the northern region of the state. She also has a franchise model that she hopes to utilize to grow the brand nationally and even abroad.

"It was hard to educate the public on what we can do on those trucks," Eick adds "It took the first year, and once the word started to get out, then it snowballed."

Contributing to the snowball effect was the pandemic, which led pet owners to looking into alternative ways to access vet treatment. Now, Eick is focused on growing her team to support the company's growth. And, she adds, this is no easy task in today's employment climate.

"In this day and age, everyone has a shortage. ... The workforce is just smaller," Eick says. "There's a nationwide shortage of vets, and it's a confluence of things that have happened that I wished we saw coming."

Eick explains how the level of care vets are now able to — and expected to — give has increased with new technologies, specialist practices, and more. But the number of new vets with each graduating class has remained the same. Retention is also an issue, as the toll on veterinarians' mental health takes providing such frequent end of life care — on top of an increasingly busier schedule.

Eick shares more on the show about her observations on the current challenges within the industry as well as how she's innovating within her own practice to combat these obstacles. Listen to the interview below — or wherever you stream your podcasts — and subscribe for weekly episodes.


This week's roundup of Houston innovators includes Enrique Gomez of Texas Medical Center Innovation, Katie Eick of Rockin' Pets Rollin' Vets, and Jim Gable of Chevron. Courtesy photos

3 Houston innovators to know this week

who's who

Editor's note: In this week's roundup of Houston innovators to know, I'm introducing you to three local innovators across industries — from health care innovation to energy — recently making headlines in Houston innovation.

Enrique Gomez, entrepreneur in residence at Texas Medical Center Innovation

Enrique Gomez joins the Houston Innovators Podcast to discuss Houston as an oncology innovation hub. Photo via TMC.edu

When it comes to leading oncology innovation, Houston has a seat at the table, Enrique Gomez, entrepreneur in residence at Texas Medical Center Innovation's Accelerator for Cancer Therapeutics, says on the Houston Innovators Podcast.

"Houston is a place where everyone looks at when it comes to novel research and approaches to treating cancer," Gomez says. "The landscape here is going to be accelerated because we see much more collaboration between the founding institutions — and that's a very important element of growth. Houston has no comparison to any other place in terms of what's going on here and the level and quality of research."Click here to read more and stream the episode.

Katie Eick, founder of Rollin' Vets

Katie Eick always wanted to be able to offer mobile services. Photo courtesy of Rollin' Vets

Houston-based Rockin' Pets, Rollin' Vets, a full-service mobile veterinary clinic based in Houston, has closed a $5 million equity raise with plans to expand across the Lone Star State. Founded by Dr. Katie Eick, who is the company's CEO, Rollin’ Vets Group flips the switch on pet health care by bringing vets to its patients' homes.

This fresh funding helps Eick take that first step toward expansion. According to a news release, Rockin’ Pets, Rollin’ Vets expects to have a presence in Dallas and Austin by March of next year.

“This equity raise allows us to not only hire additional talent, but also increase our mobile clinic fleet, while expanding into other cities at an expedited rate. There is a vast opportunity to serve animals and people that need non-traditional veterinary care in other Texas markets. We are ready to tap into these markets and bring convenient, state-of-the-art care straight to pet owners’ doorsteps,” says Eick in the release. Click here to read more.

Jim Gable, incoming vice president of innovation and president of Chevron Technology Ventures

Barbara Burger has led Chevron's innovation efforts for almost a decade and is passing the responsibilities to Jim Gable. Photo courtesy

Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures, is retiring, and passing the role to Jim Gable.

Gable brings his 23 years of experience to the role. Based in Chevron's office on the West Coast, he will be relocating to Houston, per the release. He currently oversees the development and deployment of downstream-related technology for Chevron.

“CTV has a 22-year history of investing in startups across a wide cross section of energy innovation and a track record of collaboration to bring innovation to scale,” Bonner continues. “Jim’s experience at Chevron is deep and diverse. Combined with his technology commercialization experience with CTV early in his career, as well as in his current role, Jim is poised to lead CTV to even greater success.” Click here to read more.

You'll paw-bably soon be seeing Rockin' Pets, Rollin' Vets vans across the Lone Star State. Photo courtesy of Rockin' Pets, Rollin' Vets

Houston mobile vet startup raises $5M to expand statewide

rollin' across texas

An innovative Houston company has closed a fresh round of funding in hopes of rolling its service out statewide.

Rockin' Pets, Rollin' Vets, a full-service mobile veterinary clinic based in Houston, has closed a $5 million equity raise with plans to expand across the Lone Star State. Founded by Dr. Katie Eick, who is the company's CEO, Rollin’ Vets Group flips the switch on pet health care by bringing vets to its patients' homes.

This fresh funding helps Eick take that first step toward expansion. According to a news release, Rockin’ Pets, Rollin’ Vets expects to have a presence in Dallas and Austin by March of next year.

“This equity raise allows us to not only hire additional talent, but also increase our mobile clinic fleet, while expanding into other cities at an expedited rate. There is a vast opportunity to serve animals and people that need non-traditional veterinary care in other Texas markets. We are ready to tap into these markets and bring convenient, state-of-the-art care straight to pet owners’ doorsteps,” says Eick in the release.

Currently, the company has five mobile units staffed by seven veterinarians and 12 skilled veterinary technicians. The company’s capabilities include wellness and illness exams, in-house labs, radiology, end-of-life care, routine surgeries, laser therapy and dental procedures — all within the Greater Houston area. The service plans to expand into The Woodlands in January.

Last year, the company raised $1 million in angel investment and crowdfunding on NextSeed. Patrick Lewis, CFO for Rollin’ Vets Group, says in the release that the capital was raised by a number of individuals, many of whom had prior investments in the pet care industry.

Eick founded her company in 2015 and was seeing steady growth as delivery and on-demand services like Uber, DoorDash, etc. increased in use and awareness of mobile services. Eick previously told InnovationMap that the pandemic really cemented the efficacy of mobile services.

While the company is focused on a Texas expansion for now, it's been in Eick's plan to expand even more broadly for a while.

"We're aiming to be a nationwide brand," Eick previously told InnovationMap.

Katie Eick always wanted to be able to offer mobile services.Photo courtesy of Rollin' Vets

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

3 Houston startups named most innovative in Texas by LexisNexis

report card

Three Houston companies claimed spots on LexisNexis's 10 Most Innovative Startups in Texas report, with two working in the geothermal energy space.

Sage Geosystems claimed the No. 3 spot on the list, and Fervo Energy followed closely behind at No. 5. Fintech unicorn HighRadius rounded out the list of Houston companies at No. 8.

LexisNexis Intellectual Property Solutions compiled the report. It was based on each company's Patent Asset Index, a proprietary metric from LexisNexis that identifies the strength and value of each company’s patent assets based on factors such as patent quality, geographic scope and size of the portfolio.

Houston tied with Austin, each with three companies represented on the list. Caris Life Sciences, a biotechnology company based in Dallas, claimed the top spot with a Patent Asset Index more than 5 times that of its next competitor, Apptronik, an Austin-based AI-powered humanoid robotics company.

“Texas has always been fertile ground for bold entrepreneurs, and these innovative startups carry that tradition forward with strong businesses based on outstanding patent assets,” Marco Richter, senior director of IP analytics and strategy for LexisNexis Intellectual Property Solutions, said in a release. “These companies have proven their innovation by creating the most valuable patent portfolios in a state that’s known for game-changing inventions and cutting-edge technologies.We are pleased to recognize Texas’ most innovative startups for turning their ideas into patented innovations and look forward to watching them scale, disrupt, and thrive on the foundation they’ve laid today.”

This year's list reflects a range in location and industry. Here's the full list of LexisNexis' 10 Most Innovative Startups in Texas, ranked by patent portfolios.

  1. Caris (Dallas)
  2. Apptronik (Austin)
  3. Sage Geosystems (Houston)
  4. HiddenLayer (Austin)
  5. Fervo Energy (Houston)
  6. Plus One Robotics (San Antonio)
  7. Diligent Robotics (Austin)
  8. HighRadius (Houston)
  9. LTK (Dallas)
  10. Eagle Eye Networks (Austin)

Sage Geosystems has partnered on major geothermal projects with the United States Department of Defense's Defense Innovation Unit, the U.S. Air Force and Meta Platforms. Sage's 3-megawatt commercial EarthStore geothermal energy storage facility in Christine, Texas, was expected to be completed by the end of last year.

Fervo Energy fully contracted its flagship 500 MW geothermal development, Cape Station, this spring. Cape Station is currently one of the world’s largest enhanced geothermal systems (EGS) developments, and the station will begin to deliver electricity to the grid in 2026. The company was recently named North American Company of the Year by research and consulting firm Cleantech Group and came in at No. 6 on Time magazine and Statista’s list of America’s Top GreenTech Companies of 2025. It's now considered a unicorn, meaning its valuation as a private company has surpassed $1 billion.

Meanwhile, HighRadius announced earlier this year that it plans to release a fully autonomous finance platform for the "office of the CFO" by 2027. The company reached unicorn status in 2020.

---

This article originally appeared on Energy Capital HTX.

UH student earns prestigious award for cancer vaccine research

up-and-comer

Cole Woody, a biology major in the College of Natural Sciences and Mathematics at the University of Houston, has been awarded a Barry Goldwater Scholarship, becoming the first sophomore in UH history to earn the prestigious prize for research in natural sciences, mathematics and engineering.

Woody was recognized for his research on developing potential cancer vaccines through chimeric RNAs. The work specifically investigates how a vaccine can more aggressively target cancers.

Woody developed the MHCole Pipeline, a bioinformatic tool that predicts peptide-HLA binding affinities with nearly 100 percent improvement in data processing efficiency. The MHCole Pipeline aims to find cancer-specific targets and develop personalized vaccines. Woody is also a junior research associate at the UH Sequencing Core and works in Dr. Steven Hsesheng Lin’s lab at MD Anderson Cancer Center.

“Cole’s work ethic and dedication are unmatched,” Preethi Gunaratne, director of the UH Sequencing Core and professor of Biology & Biochemistry at NSM, said in a news release. “He consistently worked 60 to 70 hours a week, committing himself to learning new techniques and coding the MHCole pipeline.”

Woody plans to earn his MD-PhD and has been accepted into the Harvard/MIT MD-PhD Early Access to Research Training (HEART) program. According to UH, recipients of the Goldwater Scholarship often go on to win various nationally prestigious awards.

"Cole’s ability to independently design and implement such a transformative tool at such an early stage in his career demonstrates his exceptional technical acumen and creative problem-solving skills, which should go a long way towards a promising career in immuno-oncology,” Gunaratne added in the release.

Houston founder on shaping the future of medicine through biotechnology and resilience

Guest Column

Living with chronic disease has shaped my life in profound ways. My journey began in 5th grade when I was diagnosed with Scheuermann’s disease, a degenerative disc condition that kept me sidelined for an entire year. Later, I was diagnosed with hereditary neuropathy with liability to pressure palsies (HNPP), a condition that significantly impacts nerve recovery. These experiences didn’t just challenge me physically, they reshaped my perspective on healthcare — and ultimately set me on my path to entrepreneurship. What started as personal health struggles evolved into a mission to transform patient care through innovative biotechnology.

A defining part of living with these conditions was the diagnostic process. I underwent nerve tests that involved electrical shocks to my hands and arms — without anesthesia — to measure nerve activity. The pain was intense, and each test left me thinking: There has to be a better way. Even in those difficult moments, I found myself thinking about how to improve the tools and processes used in healthcare.

HNPP, in particular, has been a frustrating condition. For most people, sleeping on an arm might cause temporary numbness that disappears in an hour. For me, that same numbness can last six months. Even more debilitating is the loss of strength and fine motor skills. Living with this reality forced me to take an active role in understanding my health and seeking solutions, a mindset that would later shape my approach to leadership.

Growing up in Houston, I was surrounded by innovation. My grandfather, a pioneering urologist, was among the first to introduce kidney dialysis in the city in the 1950s. His dedication to advancing patient care initially inspired me to pursue medicine. Though my path eventually led me to healthcare administration and eventually biotech, his influence instilled in me a lifelong commitment to medicine and making a difference.

Houston’s thriving medical and entrepreneurial ecosystems played a critical role in my journey. The city’s culture of innovation and collaboration provided opportunities to explore solutions to unmet medical needs. When I transitioned from healthcare administration to founding biotech companies, I drew on the same resilience I had developed while managing my own health challenges.

My experience with chronic disease also shaped my leadership philosophy. Rather than accepting diagnoses passively, I took a proactive approach questioning assumptions, collaborating with experts, and seeking new solutions. These same principles now guide decision-making at FibroBiologics, where we are committed to developing groundbreaking therapies that go beyond symptom management to address the root causes of disease.

The resilience I built through my health struggles has been invaluable in navigating business challenges. While my early career in healthcare administration provided industry insights, launching and leading companies required the same determination I had relied on in my personal health journey.

I believe the future of healthcare lies in curative treatments, not just symptom management. Fibroblast cells hold the promise of engaging the body’s own healing processes — the most powerful cure for chronic diseases. Cell therapy represents both a scientific breakthrough and a significant business opportunity, one that has the potential to improve patient outcomes while reducing long-term healthcare costs.

Innovation in medicine isn’t just about technology; it’s about reimagining what’s possible. The future of healthcare is being written today. At FibroBiologics, our mission is driven by more than just financial success. We are focused on making a meaningful impact on patients’ lives, and this purpose-driven approach helps attract talent, engage stakeholders, and differentiate in the marketplace. Aligning business goals with patient needs isn’t just the right thing to do, it’s a powerful model for sustainable growth and lasting innovation in biotech.

---

Pete O’Heeron is the CEO and founder of FibroBiologics, a Houston-based regenerative medicine company.